Can you find me one actual reference to Bavituximab in the published papers? Can you find me one mention of Peregrine in the materials section of those abstracts. They usually say who they got the materials from. Was Thorpe referenced in the papers? Do you have emails or other proof that this latest paper is generating "much discussion" anywhere but here? I'm beginning to believe that the only discussion is among a few investors you are in contact with. Does it make sense to you that IF bavi is all is is supposed to be that we'd be at 31 cents right now?
News 
Market Data 
Discover 
AI
